| Dr Amanda Azan, DDS | |
|
13200 W 95th St, Lenexa, KS 66215-3731 | |
| (913) 888-8333 | |
| Not Available |
| Full Name | Dr Amanda Azan |
|---|---|
| Gender | Female |
| Speciality | Dentist |
| Location | 13200 W 95th St, Lenexa, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154805810 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 122300000X | Dentist | 2018032604 (Missouri) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Amanda Azan, DDS 3709 Ne Ellison Dr, Lees Summit, MO 64064-1939 Ph: (816) 719-3220 | Dr Amanda Azan, DDS 13200 W 95th St, Lenexa, KS 66215-3731 Ph: (913) 888-8333 |
News Archive
Noveko International Inc. ("the Company") today announces the financial results for its fourth quarter and fiscal year ended June 30, 2009.
Amicus Therapeutics today announced that additional positive data from the ongoing Phase 2 extension study of its investigational drug Amigal™ (migalastat HCl) for Fabry disease will be presented at the Lysosomal Disease Network WORLD Symposium in Las Vegas, Nevada, February 16-18th, 2011.
A detailed structural picture of a molecule that plays a key role in activating the Epstein Barr Virus in human cells has now been obtained by researchers at the European Molecular Biology Laboratory (EMBL) and the Institute of Molecular and Structural Virology (IVMS), associated with the University Joseph Fourier and the CNRS, in Grenoble.
Sosei Group Corporation, the biopharmaceutical company, today announced that Sosei R&D Ltd., its wholly owned UK subsidiary, has entered into an agreement to assign its rights to the assets of AD 923, an optimised, sublingual formulation of the opioid analgesic fentanyl for the treatment of cancer breakthrough pain, as well as to the device for drug administration to Pharmasol R&D Ltd., a privately held UK company.
Cell Therapeutics, Inc. today announced the European Medicines Agency Pediatric Committee recommended the Company submit an updated Pediatric Investigation Plan for pixantrone following discussions with the Company about the preclinical and clinical pixantrone data, including PIX301, and the desire to explore the potential benefits pixantrone may offer to children with hematologic cancer.
› Verified 1 days ago
Dr. Steven Jay Pierce, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 8615 Rosehill Rd, Lenexa, KS 66215 Phone: 913-888-2882 Fax: 913-888-2858 | |
Dr. Steven Wayne Blum Jr., D.D.S. Dentist Medicare: Medicare Enrolled Practice Location: 19613 W 101st St, Lenexa, KS 66220 Phone: 913-390-5110 Fax: 913-390-5664 | |
Richard Eugene Miller Jr., DDS Dentist Medicare: Medicare Enrolled Practice Location: 12136 W 87th St Pkwy, Lenexa, KS 66215 Phone: 913-492-5052 Fax: 913-492-7039 | |
Dr. James I Chou, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 13254 W 98th St, Lenexa, KS 66215 Phone: 913-669-9848 | |
Dr. Dennis Dean Gemar, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 9664 Quivira Rd, Lenexa, KS 66215 Phone: 913-888-8333 Fax: 913-888-7764 | |
Ashley E Knight, DDS Dentist Medicare: Medicare Enrolled Practice Location: 8615 Rosehill Rd, Greystone Professional Building, Lenexa, KS 66215 Phone: 913-888-2882 Fax: 913-888-2858 |